Category: Business conditions
-
U.S. Public Divided Over GM, Organic Food
The American public is almost evenly divided about the benefits of genetically-modified and organic food, with those divisions not breaking along easily defined or familiar lines.
-
Targeted Leukemia Drugs Sharply Raising Costs of Care
Drugs directly attacking cancer cell growth show high remission rates with a common form of leukemia, but a new study suggests the high costs of these drugs could impose difficult economic burdens on patients and the health care system.
-
Malnutrition Shown Adding Billions to U.S. Health Costs
An analysis of data from health surveys shows malnutrition associated with 8 common chronic diseases adds $15.5 billion directly to U.S. health care costs.
-
Science News Service Hacked, Taken Offline
14 September 2016. EurekAlert, an online scientific news distribution service, was taken down last night after discovering a security breach that occurred on Friday, 9 September. An investigation by American Association for the Advancement of Science, or AAAS, that publishes EurekAlert, shows “registrants’ user names and passwords were compromised.” A letter posted by Ginger Pinholster,…
-
PhRMA: 258 Vaccines in Clinical Development
An industry group of American pharmaceutical makers says its companies have 258 vaccines, including immunotherapies, in clinical trials or awaiting FDA approval.
-
GMOs, 3D-Printed Chocolate, And The Rapid Development Of Food Technology
New, emerging technology is assisting us to analyze, track and organize the way we produce and consume food.
-
Kauffman Index Shows Higher Start-Up Growth in 2016
8 June 2016. An index of high-growth start-up companies shows the rate of entrepreneurial expansion in the U.S. accelerated for the third year in a row, with greatest concentration of growing enterprises found in the Washington, D.C. region. The Ewing Marion Kauffman Foundation in Kansas City, Missouri yesterday issued its annual Index of Growth Entrepreneurship…
-
Why Design Alone Isn’t Enough for a Successful Website
– Sponsored Content – (3 June 2016) When working on your website, try not to get too caught up in what it will look like. Sure, the overall design and attractiveness of your site is really important, but in order for it to be a true asset to your brand and business, you need to…
-
Another Chance to Get Serious on Drug Pricing
Stephen Ubl, president and CEO of Pharmaceutical Research and Manufacturers of America, or PhRMA, told a press and industry event in Washington, D.C. on Wednesday (25 May) that drug makers are eager to develop more individualized treatments for patients, but proposed regulations on drug pricing threaten that progress. Ubl also suggested, however, at the Annual…
-
Pricing Factors Proposed for Gene Therapies
Updated 27 May 2016. See Another Chance to Get Serious on Drug Pricing. A pediatric cancer specialist and venture capital executive argue for establishing a framework for pricing gene therapies to treat inherited and other diseases, before these treatments are approved by FDA. Stuart Orkin, a pediatric oncologist and hematologist at Dana-Farber Cancer Research Center…